European life sciences venture capital firm, Forbion, has announced the final close of its Forbion Growth 1 Fund at €360m (US$428m). The fund is focused on investing in late-stage life…
European life sciences venture capital firm, Forbion, has announced the final close of its Forbion Growth 1 Fund at €360m (US$428m). The fund is focused on investing in late-stage life…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


